Next, we further analyzed the expression diversity of ATP5B in breast cancer using TCGA BRCA dataset, and the results showed that ATP5B expression was significantly up-regulated in tumors of stages II–IV compared with normal tissues (Figure 3A), and the expression in stage IV was the highest. This evidence concerns the gene ATP5F1B and breast carcinoma.